Optimizing premedications for multiple sclerosis patients treated with ocrelizumab: A randomized controlled trial.
Abbasi Kasbi N, Rezaei A, Montazeri R, Nikkhah Bahrami S, Rezaeimanesh N, Arab Bafrani M, Ghane Ezabadi S, Kohandel K, Khodaie F, Jahani S, Naser Moghadasi A, Azimi Saeen A, Navardi S, Heidari H, Ebadi Z, Sahraian MA.
Abbasi Kasbi N, et al.
Mult Scler J Exp Transl Clin. 2025 Aug 10;11(3):20552173251359074. doi: 10.1177/20552173251359074. eCollection 2025 Jul-Sep.
Mult Scler J Exp Transl Clin. 2025.
PMID: 40799203
Free PMC article.